These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 16336586

  • 1. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF, Milena FJ, Mora C, León C, Claverie F, Flores C, García J.
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [Abstract] [Full Text] [Related]

  • 2. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF, Milena FJ, Mora C, León C, García J.
    Am J Nephrol; 2006 Dec; 26(6):562-70. PubMed ID: 17167242
    [Abstract] [Full Text] [Related]

  • 3. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [Abstract] [Full Text] [Related]

  • 4. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 5. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 6. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [Abstract] [Full Text] [Related]

  • 7. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM, Anderson S.
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [Abstract] [Full Text] [Related]

  • 8. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 9. Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli.
    Fukui M, Nakamura T, Ebihara I, Makita Y, Osada S, Tomino Y, Koide H.
    J Lab Clin Med; 1994 May; 123(5):763-8. PubMed ID: 8195682
    [Abstract] [Full Text] [Related]

  • 10. Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.
    Komers R, Tian W, Lindsley JN, Oyama TT, Cohen DM, Anderson S.
    J Lab Clin Med; 2002 Nov; 140(5):351-7. PubMed ID: 12434137
    [Abstract] [Full Text] [Related]

  • 11. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 Jul 28; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 13. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
    Nielsen B, Grønbaek H, Osterby R, Flyvbjerg A.
    Exp Diabesity Res; 2003 Jul 28; 4(3):191-9. PubMed ID: 15061647
    [Abstract] [Full Text] [Related]

  • 14. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
    Navarro JF, Mora C, Muros M, García J.
    J Am Soc Nephrol; 2005 Jul 28; 16(7):2119-26. PubMed ID: 15917336
    [Abstract] [Full Text] [Related]

  • 15. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Jul 28; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 16. Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats.
    Moriwaki Y, Inokuchi T, Yamamoto A, Ka T, Tsutsumi Z, Takahashi S, Yamamoto T.
    Acta Diabetol; 2007 Dec 28; 44(4):215-8. PubMed ID: 17767370
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O, Allegrini J, Clozel JP, Ménard J, Alhenc-Gelas F.
    J Pharmacol Exp Ther; 1998 Mar 28; 284(3):1180-7. PubMed ID: 9495881
    [Abstract] [Full Text] [Related]

  • 18. Identification of angiotensin converting enzyme 2 in the rodent retina.
    Tikellis C, Johnston CI, Forbes JM, Burns WC, Thomas MC, Lew RA, Yarski M, Smith AI, Cooper ME.
    Curr Eye Res; 2004 Dec 28; 29(6):419-27. PubMed ID: 15764086
    [Abstract] [Full Text] [Related]

  • 19. Role of angiotensin II, endothelin-1, and nitric oxide in HgCl2-induced acute renal failure.
    Yanagisawa H, Nodera M, Umemori Y, Shimoguchi Y, Wada O.
    Toxicol Appl Pharmacol; 1998 Oct 28; 152(2):315-26. PubMed ID: 9853001
    [Abstract] [Full Text] [Related]

  • 20. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ.
    Diabetes Metab Res Rev; 2003 Oct 28; 19(6):469-77. PubMed ID: 14648806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.